Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective study

DOI: 10.4251/wjgo.v11.i8.634

Keywords: Gastric cancer, Neoadjuvant chemotherapy, TeFOX, Retrospective study

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text